8.23
price up icon1.35%   0.11
after-market After Hours: 8.20 -0.03 -0.36%
loading
Personalis Inc stock is traded at $8.23, with a volume of 861.06K. It is up +1.35% in the last 24 hours and up +40.68% over the past month. Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$8.12
Open:
$8.33
24h Volume:
861.06K
Relative Volume:
0.89
Market Cap:
$729.81M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-3.6578
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
+14.31%
1M Performance:
+40.68%
6M Performance:
+151.30%
1Y Performance:
+74.00%
1-Day Range:
Value
$7.8207
$8.54
1-Week Range:
Value
$7.18
$8.85
52-Week Range:
Value
$2.8262
$8.85

Personalis Inc Stock (PSNL) Company Profile

Name
Name
Personalis Inc
Name
Phone
650-752-1300
Name
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Name
Employee
229
Name
Twitter
@PersonalisInc
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PSNL's Discussions on Twitter

Compare PSNL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
PSNL
Personalis Inc
8.23 720.06M 73.48M -108.30M -67.17M -2.25
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.58 198.17B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
205.14 144.97B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
633.32 49.29B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
138.23 38.73B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
203.77 33.69B 15.70B 1.24B 2.01B 6.9036

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-25 Initiated Guggenheim Buy
Mar-17-25 Initiated Craig Hallum Buy
Feb-06-23 Upgrade Needham Hold → Buy
Jan-07-22 Upgrade BofA Securities Neutral → Buy
Nov-05-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-03-21 Downgrade Needham Buy → Hold
Oct-15-21 Resumed Cowen Outperform
Sep-20-21 Reiterated Needham Buy
May-06-21 Upgrade Oppenheimer Perform → Outperform
Jan-28-21 Initiated Truist Buy
Jan-04-21 Downgrade BofA Securities Buy → Neutral
Nov-12-20 Reiterated Needham Buy
Nov-06-20 Downgrade Oppenheimer Outperform → Perform
Oct-19-20 Initiated Citigroup Buy
Oct-08-20 Initiated BTIG Research Buy
Aug-27-20 Initiated H.C. Wainwright Buy
Aug-18-20 Initiated Needham Buy
Sep-26-19 Upgrade BofA/Merrill Neutral → Buy
Jul-15-19 Initiated BofA/Merrill Neutral
Jul-15-19 Initiated Cowen Outperform
Jul-15-19 Initiated Morgan Stanley Overweight
Jul-15-19 Initiated Oppenheimer Outperform
View All

Personalis Inc Stock (PSNL) Latest News

pulisher
11:23 AM

Real time scanner hits for Personalis Inc. explainedCPI Data & Safe Capital Growth Tips - newser.com

11:23 AM
pulisher
11:06 AM

Why Personalis Inc. stock remains on watchlistsJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com

11:06 AM
pulisher
10:56 AM

Will Personalis Inc. stock see PE expansion2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com

10:56 AM
pulisher
10:55 AM

Will Personalis Inc. see short term momentumChart Signals & AI Enhanced Trading Signals - newser.com

10:55 AM
pulisher
08:54 AM

Is Personalis Inc. stock ready for breakoutMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com

08:54 AM
pulisher
05:03 AM

Will breakout in Personalis Inc. lead to full recoveryWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com

05:03 AM
pulisher
02:26 AM

Will Personalis Inc. stock gain from government policiesPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com

02:26 AM
pulisher
12:46 PM

Price momentum metrics for Personalis Inc. explainedQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com

12:46 PM
pulisher
Oct 12, 2025

Analyzing net buyer seller activity in Personalis Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Will Personalis Inc. benefit from macro trends2025 Pullback Review & AI Powered Market Trend Analysis - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Personalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Oct 12, 2025
pulisher
Oct 10, 2025

How to monitor Personalis Inc. with trend dashboardsWeekly Market Outlook & Precise Buy Zone Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Visual trend scoring systems applied to Personalis Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Forecasting Personalis Inc. price range with options dataEarnings Growth Report & Safe Capital Growth Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Personalis, Inc. Hits New 52-Week High of $8.70, Up 557.58% - Markets Mojo

Oct 09, 2025
pulisher
Oct 09, 2025

Understanding Personalis Inc.’s price movementPortfolio Return Report & Community Trade Idea Sharing - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What MACD signals say about Personalis Inc.Quarterly Trade Report & Weekly Momentum Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Analyzing Personalis Inc. with risk reward ratio chartsDividend Hike & AI Optimized Trading Strategy Guides - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Personalis (NASDAQ:PSNL) Reaches New 1-Year HighHere's What Happened - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Head-To-Head Review: Parnell Pharmaceuticals (OTCMKTS:PARNF) versus Personalis (NASDAQ:PSNL) - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st

Oct 07, 2025
pulisher
Oct 07, 2025

What analysts say about Personalis Inc 04X stockMarket Timing Techniques & Free Get High Impact Recommendations - earlytimes.in

Oct 07, 2025
pulisher
Oct 05, 2025

Exit strategy if you’re trapped in Personalis Inc.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why Personalis Inc. stock could be next big winner2025 Investor Takeaways & AI Driven Price Forecasts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What indicators show strength in Personalis Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Personalis Inc. stock outperform tech sector in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Personalis (NASDAQ:PSNL) Trading 8.9% HigherStill a Buy? - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Volume spikes in Personalis Inc. stock – what they meanJuly 2025 Action & Free Long-Term Investment Growth Plans - newser.com

Oct 03, 2025
pulisher
Sep 28, 2025

What drives Personalis Inc stock priceSwing Trading Watchlist & Identify Winning Stocks - earlytimes.in

Sep 28, 2025
pulisher
Sep 23, 2025

Goldman Sachs Group Inc. Has $998,000 Stock Position in Personalis, Inc. $PSNL - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Personalis (NASDAQ:PSNL) Upgraded at Wall Street Zen - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Personalis (NASDAQ:PSNL) Trading 7.5% HigherHere's Why - MarketBeat

Sep 22, 2025

Personalis Inc Stock (PSNL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Personalis Inc Stock (PSNL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Tachibana Aaron
CFO AND COO
Jul 28 '25
Sale
6.57
641
4,211
164,458
Tachibana Aaron
CFO AND COO
May 16 '25
Sale
4.95
1,291
6,390
165,099
Moore Stephen Michael
SVP and Chief Legal Officer
May 16 '25
Sale
4.95
1,675
8,291
64,200
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
May 16 '25
Sale
4.95
910
4,504
124,957
Tachibana Aaron
CFO AND COO
Jan 28 '25
Sale
5.79
708
4,099
166,390
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
Jan 28 '25
Sale
5.79
519
3,005
123,367
Chen Richard
CHIEF MEDICAL OFFICER AND EVP
Dec 16 '24
Sale
3.82
4,834
18,466
123,886
Moore Stephen Michael
SVP and Chief Legal Officer
Dec 16 '24
Sale
3.82
1,513
5,780
65,875
Tachibana Aaron
CFO AND COO
Dec 16 '24
Sale
3.82
6,865
26,224
167,098
Tachibana Aaron
CFO AND COO
Nov 18 '24
Sale
3.79
1,307
4,954
173,963
diagnostics_research WAT
$336.33
price up icon 1.61%
diagnostics_research DGX
$182.78
price down icon 0.70%
diagnostics_research LH
$276.64
price down icon 0.45%
$174.17
price up icon 2.89%
diagnostics_research MTD
$1,284.74
price up icon 0.87%
diagnostics_research IQV
$203.77
price up icon 2.83%
Cap:     |  Volume (24h):